A study published in the Journal of Clinical Investigation suggests severe COVID infections may help reduce cancer. Research on mice found that specific monocytes induced by COVID fought cancer cells.
The study 'Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase ...